Literature DB >> 24011704

Report of the first Outcome Measures in Myotonic Dystrophy type 1 (OMMYD-1) international workshop: Clearwater, Florida, November 30, 2011.

Cynthia Gagnon1, Giovanni Meola, Luc J Hébert, Jack Puymirat, Luc Laberge, Mario Leone.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24011704     DOI： 10.1016/j.nmd.2013.07.004

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN： 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  12 in total

1.  Tractography reveals diffuse white matter abnormalities in Myotonic Dystrophy Type 1.

Authors:  Jeffrey R Wozniak; Bryon A Mueller; Kelvin O Lim; Laura S Hemmy; John W Day
Journal:  J Neurol Sci       Date:  2014-04-13       Impact factor: 3.181

2.  Patient-Centered Core Impact Sets: What They are and Why We Need Them.

Authors:  Eleanor M Perfetto; Elisabeth M Oehrlein; T Rosie Love; Silke Schoch; Annie Kennedy; Jennifer Bright
Journal:  Patient       Date:  2022-06-02       Impact factor: 3.481

3.  Brief assessment of cognitive function in myotonic dystrophy: Multicenter longitudinal study using computer-assisted evaluation.

Authors:  Gayle K Deutsch; Katharine A Hagerman; Jacinda Sampson; Gersham Dent; Jeanne Dekdebrun; Dana M Parker; Charles A Thornton; Chad R Heatwole; Sub H Subramony; Ami K Mankodi; Tetsuo Ashizawa; Jeffrey M Statland; W David Arnold; Richard T Moxley; John W Day
Journal:  Muscle Nerve       Date:  2022-02-28       Impact factor: 3.852

4.  Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA).

Authors:  Giovanni DiPaolo; Cecilia Jimenez-Moreno; Nikoletta Nikolenko; Antonio Atalaia; Darren G Monckton; Michela Guglieri; Hanns Lochmüller
Journal:  J Neurol       Date:  2017-02-06       Impact factor: 4.849

5.  Analysis of the functional capacity outcome measures for myotonic dystrophy.

Authors:  Aura Cecilia Jimenez-Moreno; Nikoletta Nikolenko; Marie Kierkegaard; Alasdair P Blain; Jane Newman; Charlotte Massey; Dionne Moat; Jas Sodhi; Antonio Atalaia; Grainne S Gorman; Chris Turner; Hanns Lochmüller
Journal:  Ann Clin Transl Neurol       Date:  2019-07-22       Impact factor: 4.511

6.  Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up study.

Authors:  Garazi Labayru; Jone Aliri; Miren Zulaica; Adolfo López de Munain; Andone Sistiaga
Journal:  J Neuropsychol       Date:  2019-08-13       Impact factor: 2.864

7.  International Workshop:: Outcome measures and clinical trial readiness in primary mitochondrial myopathies in children and adults. Consensus recommendations. 16-18 November 2016, Rome, Italy.

Authors:  Michelangelo Mancuso; Robert McFarland; Thomas Klopstock; Michio Hirano
Journal:  Neuromuscul Disord       Date:  2017-09-08       Impact factor: 4.296

8.  Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease.

Authors:  Libby Wood; Guillaume Bassez; Corinne Bleyenheuft; Craig Campbell; Louise Cossette; Aura Cecilia Jimenez-Moreno; Yi Dai; Hugh Dawkins; Jorge Alberto Diaz Manera; Celine Dogan; Rasha El Sherif; Barbara Fossati; Caroline Graham; James Hilbert; Kristinia Kastreva; En Kimura; Lawrence Korngut; Anna Kostera-Pruszczyk; Christopher Lindberg; Bjorn Lindvall; Elizabeth Luebbe; Anna Lusakowska; Radim Mazanec; Giovani Meola; Liannna Orlando; Masanori P Takahashi; Stojan Peric; Jack Puymirat; Vidosava Rakocevic-Stojanovic; Miriam Rodrigues; Richard Roxburgh; Benedikt Schoser; Sonia Segovia; Andriy Shatillo; Simone Thiele; Ivailo Tournev; Baziel van Engelen; Stanislav Vohanka; Hanns Lochmüller
Journal:  Orphanet J Rare Dis       Date:  2018-09-05       Impact factor: 4.123

9.  Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy.

Authors:  Edward Callus; Enrico G Bertoldo; Maria Beretta; Sara Boveri; Rosanna Cardani; Barbara Fossati; Elisa Brigonzi; Giovanni Meola
Journal:  Front Neurol       Date:  2018-09-19       Impact factor: 4.003

10.  Outcome Measures for Central Nervous System Evaluation in Myotonic Dystrophy Type 1 May Be Confounded by Deficits in Motor Function or Insight.

Authors:  Mark J Hamilton; John McLean; Sarah Cumming; Bob Ballantyne; Josephine McGhie; Ravi Jampana; Cheryl Longman; Jonathan J Evans; Darren G Monckton; Maria Elena Farrugia
Journal:  Front Neurol       Date:  2018-10-02       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.